Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06136221 · ClinicalTrials.gov registry record · NA
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
A NA study of Physical Inactivity and Cirrhosis, Liver, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 2
- Study locations
NCT06136221: Recruiting NA study of Physical Inactivity and Cirrhosis, Liver, sponsored by University of Pennsylvania.
NCT06136221 is a NA study of Physical Inactivity and Cirrhosis, Liver that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 110 participants, below the 223-participant average among 59 other Physical Inactivity trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06136221, a NA study of Physical Inactivity and Cirrhosis, Liver, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 2
- Study locations
Study Summary
Remote healthcare monitoring for cirrhosis has shown promise in overcoming barriers to accessing specialty care, improving healthcare quality, and reducing mortality. The LiverWatch study is investigating whether a remote nutrition, physical activity, and education intervention can improve health outcomes in those with cirrhosis. In this clinical trial, individuals will be randomized to either enhanced usual care or the LiverWatch intervention. Both groups are given fitbits and asked to increase their step counts. Those in the Liverwatch group will be incentivized for increase their physical activity while also undergoing a personalized nutrition intervention and weekly symptom monitoring and cirrhosis education.
Primary Outcome
The PROMIS 29+2 assessment measures seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance). There are four questions asked for each of the domains along with the two questions pertaining to cognition. These domains are measured on a Likert scale (units: 1-5) and are universal regardless of disease state.
Conditions Studied
Interventions
- BEHAVIORAL LiverWatch Intervention
Study Locations (2)
Michigan
- University of Michigan - Ann Arbor
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT06136221 shows while recruiting
NCT06136221 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 223-participant average among 59 other Physical Inactivity trials with a reported enrollment target (51% lower).
The record links to 5 conditions, with Physical Inactivity appearing as the primary indexed condition, and to 1 intervention - of which LiverWatch Intervention is the first listed.
NCT06136221 reports a single indexed study location in Michigan, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06136221 about?
NCT06136221 is a clinical study titled "Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease". Remote healthcare monitoring for cirrhosis has shown promise in overcoming barriers to accessing specialty care, improving healthcare quality, and reducing mortality. The LiverWatch study is investigating whether a remote nutrition, physical activity, and education intervention can improve health ou...
What is the current status of trial NCT06136221?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2024-05-01. Estimated completion is 2026-05-31.
What conditions does trial NCT06136221 study?
This clinical trial studies the following conditions: Physical Inactivity, Cirrhosis, Liver, End Stage Liver DIsease, Muscle Loss, Symptoms and Signs.
What interventions are being tested in trial NCT06136221?
The interventions under investigation include: LiverWatch Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06136221?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06136221 being conducted?
This trial has 2 study locations across Michigan, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Inactivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06136221's enrollment target sits among peer trials
110 30th of 59 higher than 30 of 59 other Physical Inactivity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Physical Inactivity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Promoting Physical Activity in Older Hispanic/Latino(a) Adults
RECRUITING · NA
-
ENRICH Nurse-Family Partnership Study
RECRUITING · NA
-
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI